NEW YORK (GenomeWeb News) - Sapio Sciences said today that molecular diagnostics developer Biodesix has purchased its Exemplar laboratory information management system.

Biodesix is developing mass spectrometry-based molecular diagnostics to help physicians diagnose, treat, and monitor disease.

Sapio said that the company was looking for a LIMS that could track samples, support biobanking, and integrate with its mass spectrometry instruments.

Financial terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.